Please login to the form below

job cuts

This page shows the latest job cuts news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits Zynquista alliance with Lexicon

The blockbuster has seen a step decline in sales due to biosimilar competition in Europe and pricing pressure in the US, which has hit Sanofi hard and led to job cuts

Latest news

Boris pledges a £1.8bn cash injection for the NHS

The £1bn tranche could also be viewed as merely reversing cuts hospital trusts were asked to make this year, according to the King’s Fund. ... His largesse since taking the top job – promising tax cuts across the board and 20, 000 new police
Sanofi sheds jobs in R&D restructuring

The job cuts will mostly be in France, but reductions will also hit Germany. ... Making job cuts isn't as easy to do in these countries as it is in the US, and the company is now entering into consultations with unions, while stressing that
Pfizer drops neuroscience R&D, cutting 300 jobs

The job cuts will come mostly at its sites in Cambridge and Andover, Massachusetts, and in Groton, Connecticut, with about 100 losses expected at each.
FDA approves Sanofi's follow-on version of Lilly’s Humalog

Humalog is just one of Lilly’s big brands facing competition, along with erectile dysfunction therapy Cialis (tadalafil) and antiplatelet drug Effient (prasugrel), and the company recently announced sweeping job cuts
Teva offloads women's health unit in quickfire deals

The company has already announced several thousand job cuts and the closure or sale of six manufacturing plants this year, with another nine under threat in 2018.

More from news
Approximately 45 fully matching, plus 94 partially matching documents found.

Latest Intelligence

Pharma deals during October 2013

The month opened with the news that Merck &Co is eliminating a further 8, 500 jobs, in addition to the previously announced 7, 500 job cuts, in its plan to reduce
Partial privatisation shakes up pharma market in Spain

Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system. ... The reform is also expected to lead to significant job cuts (around 9, 000) in the public health sector, which will take place
Interview: Trevor Smith, Takeda

Confronting mortality. Significant cuts may be on their way over the next four years, but Takeda and Nycomed have perhaps already come through the hardest parts of today's pharmaceutical environment.